Back to search

University of British Columbia

Evaluation of anti-pertussis immunogenicity in infants and children after immunization in pregnancy with tetanus-diphtheria-acellular pertussis vaccine

Abstract

dc:description

Pertussis disease is most severe in young infants. Tetanus-diphtheria-acellular pertussis (Tdap) vaccine given in pregnancy increases anti-pertussis antibodies transferred to the fetus, protecting young infants from severe pertussis disease. However, infants born to Tdap-vaccinated mothers may experience immunomodulation, leading to decreased antibody responses to their own pertussis vaccines. Many low-to-middle income countries have a high incidence of pertussis disease and deaths in young infants, but Tdap is not recommended due to the lack of data, including data on the use in pregnant women living with human immunodeficiency virus (HIV). I evaluated anti-pertussis immunogenicity and antibody avidity in pregnant people living with and without HIV in Uganda that received Tdap in pregnancy, and their newborns. I hypothesized that Tdap-vaccinated pregnant people would have higher anti-pertussis antibodies compared with those that received tetanus-diphtheria (Td) vaccine, and infants born to Tdap-vaccinated mothers would have a modulated antibody response to their pertussis vaccines. Additionally, the impact of different diphtheria-tetanus-acellular pertussis (DTaP) vaccine schedules and products on immunomodulation in infants have not been explored. I evaluated 2+1 and 3+1 dose schedules with different vaccine products as a booster in children from Quebec. I hypothesized that children that received a 3+1 dose schedule would have higher antibodies and lower immunomodulation compared with children that received 2+1 doses of DTaP vaccine. Anti-pertussis toxin (PT), -filamentous hemagglutinin (FHA), and -pertactin (PRN) immunoglobulin G (IgG) concentrations were quantified by an enzyme-linked immunosorbent assay (ELISA), and anti-PT IgG avidity was measured by a modified ELISA. I found that people that received Tdap in pregnancy had higher total anti-PT and anti-FHA IgG concentrations compared to Td-vaccinated pregnant people, regardless of HIV-status. Infants from Tdap-vaccinated mothers had lower anti-PT IgG concentration after their primary series compared with infants from Td-vaccinated mothers, regardless of HIV-exposure. The proportion of antibodies with different avidities was similar between those that received the same vaccine, regardless of HIV-status. Receiving 3+1 doses compared to 2+1 doses of DTaP led to significantly higher total anti-PT, FHA, and PRN IgG concentrations with similar avidity between all groups. Overall, pertussis vaccines increase anti-pertussis antibodies, regardless of HIV-status and age.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Experimental Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Amaral, Kyle
Contributors dc:contributor
  • Sadarangani, Manish

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/87886

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Amaral, Kyle. Evaluation of anti-pertussis immunogenicity in infants and children after immunization in pregnancy with tetanus-diphtheria-acellular pertussis vaccine. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/87886